Display options
Share it on

Clin Exp Emerg Med. 2020 Jun;7(2):87-94. doi: 10.15441/ceem.19.050. Epub 2020 Jun 30.

Effect of complement C1-esterase inhibitor on brain edema and inflammation after mild traumatic brain injury in an animal model.

Clinical and experimental emergency medicine

Eric Weiss, Teena Dhir, Abigail Collett, Michal Reola, Mark Kaplan, Corrado Minimo, Laurel Omert, Pak Leung

Affiliations

  1. Department of Surgery, Einstein Healthcare Network, Philadelphia, PA, USA.
  2. Philadelphia College of Osteopathic Medicine, Philadelphia, PA, USA.
  3. Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.

PMID: 32635699 PMCID: PMC7348678 DOI: 10.15441/ceem.19.050

Abstract

OBJECTIVE: Traumatic brain injury (TBI) is characterized by damage to the blood-brain barrier, inflammation, and edema formation. In this pilot study, we aimed to investigate the effects of a complement inhibitor, C1-esterase inhibitor (C1 INH), on brain edema and inflammation in a rat model of mild TBI.

METHODS: Thirty-six male Sprague Dawley rats were randomly assigned to control, TBI, or TBI plus C1 INH groups. TBI and TBI plus C1 INH rats received an injection of saline or 25 IU/kg C1 INH, respectively, with TBI using a weight drop model. Control rats received saline only. Rats were subsequently euthanized and their brain tissue harvested for analysis. The primary outcome was the extent of edema as assessed by the brain's water content. Secondary outcomes included enzyme-linked immunosorbent assays to determine levels of pro-inflammatory mediators.

RESULTS: Tumor necrosis factor-α levels were significantly greater in TBI rats than control rats, indicating that inflammation was generated by the weight drop impact. Brain water content following TBI was significantly different between TBI rats treated with C1-INH (78.7%±0.12), untreated TBI rats (79.3%±0.12), and control rats (78.6%±0.15, P=0.001). There was a significant decrease in C3a and interleukin 2 levels among C1 INH-treated rats compared with untreated TBI rats, but no change in levels of tumor necrosis factor-α and S100β.

CONCLUSION: C1-INH inhibited the complement pathway, suggesting that C1-INH may have a therapeutic benefit in TBI. Further studies are needed to investigate the effect of C1-INH on clinical outcomes.

Keywords: Brain injuries, traumatic; Complement system proteins; Cytokines; Edema; Inflammation

References

  1. PLoS One. 2013 Aug 26;8(8):e72059 - PubMed
  2. Transl Stroke Res. 2012 Jun;3(2):263-5 - PubMed
  3. Shock. 2007 Jul;28(1):29-34 - PubMed
  4. J Neuroimmunol. 1997 Mar;73(1-2):63-9 - PubMed
  5. J Neuroinflammation. 2016 Oct 11;13(1):264 - PubMed
  6. Handb Clin Neurol. 2016;138:207-23 - PubMed
  7. J Vis Exp. 2014 Dec 08;(94): - PubMed
  8. J Neurotrauma. 2001 Dec;18(12):1295-311 - PubMed
  9. Shock. 2012 Jul;38(1):82-91 - PubMed
  10. Front Cell Neurosci. 2014 Sep 09;8:269 - PubMed
  11. Clin J Am Soc Nephrol. 2015 Sep 4;10(9):1636-50 - PubMed
  12. J Immunol. 2014 Mar 1;192(5):2339-48 - PubMed
  13. Methods Mol Biol. 2016;1462:193-209 - PubMed
  14. Crit Care Med. 2009 Feb;37(2):659-65 - PubMed
  15. J Neurotrauma. 2013 Jun 1;30(11):920-37 - PubMed
  16. Shock. 2016 Sep;46(3 Suppl 1):177-88 - PubMed
  17. Nat Rev Neurol. 2010 Jul;6(7):393-403 - PubMed
  18. Brain Res Brain Res Rev. 1998 Aug;27(3):243-56 - PubMed
  19. Protein Sci. 1994 Aug;3(8):1169-77 - PubMed
  20. Trends Pharmacol Sci. 2015 Jul;36(7):471-80 - PubMed
  21. Acta Neurochir Suppl. 2008;102:381-4 - PubMed
  22. Neurosurg Clin N Am. 2016 Oct;27(4):473-88 - PubMed
  23. J Neuroinflammation. 2018 Jan 22;15(1):24 - PubMed
  24. J Trauma. 1993 Feb;34(2):216-22 - PubMed
  25. Neurology. 2001 Jun 26;56(12):1746-8 - PubMed
  26. Acta Neurochir (Wien). 2011 Jan;153(1):90-100 - PubMed
  27. J Neurotrauma. 2001 Aug;18(8):773-81 - PubMed
  28. Thromb Haemost. 2010 Nov;104(5):886-93 - PubMed
  29. MMWR Surveill Summ. 2017 Mar 17;66(9):1-16 - PubMed

Publication Types

Grant support